Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K De Groot

Showing results (11-20 of 267) with videos related to

Pageof 27
Sort By:
Der Internist|June 16, 2007
[Renal manifestations in rheumatic diseases]K de Groot
Annals of the New York Academy of Sciences|January 1, 1988
Effect of porosity and physicochemical properties on the stability, resorption, and strength of calcium phosphate ceramicsK De Groot
Nederlands Tijdschrift Voor Geneeskunde|April 21, 1990
[Artificial implants]K de Groot
Journal of Biomedical Materials Research|May 1, 1981
In vivo surface activity of a hydroxyapatite alveolar bone substituteP Ducheyne, K de Groot
Antimicrobial Agents and Chemotherapy|November 1, 1985
Effect of the imidazole derivative lombazole on the ultrastructure of Staphylococcus epidermidis and Candida albicansD Barug, K de Groot
Journal of Biomedical Materials Research|April 1, 1989
Patent literature as a source of information for research and development: an investigation on calcium phosphate-containing biomaterials, Part IM Wüstefeld, K de Groot
Der Hautarzt; Zeitschrift Fur Dermatologie, Venerologie, Und Verwandte Gebiete|September 9, 2008
[Therapy of vasculitides and vasculopathies]C Sunderkötter, K de Groot
Zeitschrift Fur Rheumatologie|July 8, 2011
[Is methotrexate nephrotoxic? Dose-dependency, comorbidities and comedication]U Erdbrügger, K de Groot
Clinical Nephrology|December 24, 2005
What is new in the therapy of ANCA-associated vasculitides? Take home messages from the 12th workshop on ANCA and systemic vasculitidesK de Groot, D Jayne
Clinical Nephrology|June 25, 2002
Tolerance of mycophenolate mofetil in end-stage renal disease patients with ANCA-associated vasculitisM Haubitz, K de Groot
Pageof 27

Showing results (11-20 of 267) with videos related to

Sort By:
Pageof 27
Der Internist|June 16, 2007
[Renal manifestations in rheumatic diseases]K de Groot
Annals of the New York Academy of Sciences|January 1, 1988
Effect of porosity and physicochemical properties on the stability, resorption, and strength of calcium phosphate ceramicsK De Groot
Nederlands Tijdschrift Voor Geneeskunde|April 21, 1990
[Artificial implants]K de Groot
Journal of Biomedical Materials Research|May 1, 1981
In vivo surface activity of a hydroxyapatite alveolar bone substituteP Ducheyne, K de Groot
Antimicrobial Agents and Chemotherapy|November 1, 1985
Effect of the imidazole derivative lombazole on the ultrastructure of Staphylococcus epidermidis and Candida albicansD Barug, K de Groot
Journal of Biomedical Materials Research|April 1, 1989
Patent literature as a source of information for research and development: an investigation on calcium phosphate-containing biomaterials, Part IM Wüstefeld, K de Groot
Der Hautarzt; Zeitschrift Fur Dermatologie, Venerologie, Und Verwandte Gebiete|September 9, 2008
[Therapy of vasculitides and vasculopathies]C Sunderkötter, K de Groot
Zeitschrift Fur Rheumatologie|July 8, 2011
[Is methotrexate nephrotoxic? Dose-dependency, comorbidities and comedication]U Erdbrügger, K de Groot
Clinical Nephrology|December 24, 2005
What is new in the therapy of ANCA-associated vasculitides? Take home messages from the 12th workshop on ANCA and systemic vasculitidesK de Groot, D Jayne
Clinical Nephrology|June 25, 2002
Tolerance of mycophenolate mofetil in end-stage renal disease patients with ANCA-associated vasculitisM Haubitz, K de Groot
Pageof 27